Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0JO7Y
|
|||
Former ID |
DAP000319
|
|||
Drug Name |
Fulvestrant
|
|||
Synonyms |
Faslodex; AstraZeneca brand of fulvestrant; Fulvestrant [USAN]; Ici 182780; ZD 182780; ZM 182780; Faslodex (TN); ZD-182780; ZD-9238; ZM-182780; Faslodex(ICI 182,780); Faslodex, ICI 182780, Fulvestrant; Fulvestrant (JAN/USAN/INN); (7R,13S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol; (7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol; (7R,8S,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl) nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol; (7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol; 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol; 7alpha-(9-((4,4,5,5,5,-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol; 7alpha-(9-((4,4,5,5,5-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol; 7alpha-[9[(4,4,5,5,5-Pentafluropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3, 17 beta diol; ICI
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Breast cancer [ICD-11: 2C60-2C65] | Approved | [1], [2] | |
Therapeutic Class |
Anticancer Agents
|
|||
Company |
AstraZeneca
|
|||
Structure |
Download2D MOL |
|||
Formula |
C32H47F5O3S
|
|||
Canonical SMILES |
CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
|
|||
InChI |
1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-29,38-39H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29-,30+,41?/m1/s1
|
|||
InChIKey |
VWUXBMIQPBEWFH-WCCTWKNTSA-N
|
|||
CAS Number |
CAS 129453-61-8
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
534986, 7848224, 8139859, 10233578, 12014659, 14887338, 14911923, 44434356, 47213214, 48421875, 49965830, 53787559, 56310723, 56311014, 56311884, 56311948, 56312955, 57337809, 57570890, 74779769, 87325152, 90341164, 92309278, 92721810, 93165800, 93167154, 99437215, 103447197, 104054514, 104372812, 121360934, 124757068, 125163872, 126627510, 126634728, 126666851, 129538438, 134337631, 135060458, 135650370, 135916581, 136946608, 137267475, 143493372, 144115998, 144204490, 144209802, 144213958, 152035088, 152233184
|
|||
ChEBI ID |
CHEBI:31638
|
|||
ADReCS Drug ID | BADD_D00978 | |||
SuperDrug ATC ID |
L02BA03
|
|||
SuperDrug CAS ID |
cas=129453618
|
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1015). | |||
REF 2 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. | |||
REF 3 | Beta3-tubulin is induced by estradiol in human breast carcinoma cells through an estrogen-receptor dependent pathway. Cell Motil Cytoskeleton. 2009 Jul;66(7):378-88. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.